Parkworth Wealth Management’s Chemours CC Stock Holding History

Parkworth Wealth Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4	Closed	-$68	–	1238
2024 Q4	$68	Buy	+4	New	+$78	﹤0.01%	1090

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Parkworth Wealth Management's CC Position: Q1 2025 in Review

Parkworth Wealth Management sold out of Chemours (CC) in Q1 2025, closing a stake of 4 shares — an estimated $68 sold.

Parkworth Wealth Management first reported a position in CC in Q4 2024 and held it in 1 quarter. The position peaked at $68 in Q4 2024. 419 funds tracked by Wall St. Rank hold CC as of Q1 2025.

Parkworth Wealth Management reported no remaining Chemours position as of Q1 2025 after selling out during the quarter.
Parkworth Wealth Management sold 4 Chemours shares in Q1 2025, an estimated $68.
Parkworth Wealth Management first reported a position in Chemours in Q4 2024 and held it in 1 quarter.
Parkworth Wealth Management's Chemours position peaked at $68 in Q4 2024.
419 funds tracked by Wall St. Rank held Chemours as of Q1 2025.

Based on Parkworth Wealth Management's 13F filing for Q1 2025, filed 5 May 2025.